Pittampalli S, Upadyayula S, Mekala HM, Lippmann S
Research peptides exist in a different regulatory category than prescription medications, which is why they can be legally sourced in Canada while Retatrutide awaits Health Canada approval
A large analysis of over 96,000 patients found GLP-1 use associated with significantly lower odds of needing an opioid prescription or of being diagnosed with chronic pain and/or fatigue
The effect of spironolactone on morbidity and mortality in patients with severe heart failure
Across 10 studies, the incidence of thyroid cancer was less than 1%, which suggests that there is no significant risk of thyroid cancer associated with semaglutide use in humans
IGF-1 LR3 Third-Party Tested COA Available IGF-1 LR3 1 mg is a synthetic IGF-1 analog used in laboratory research for somatomedin signaling and IGF-1 receptor interaction studies